Approval was based on the phase 3 ENERGIZE and ENERGIZE-T studies evaluating the safety and efficacy of mitapivat in adults with alpha- or beta-thalassemia.

HealthDay News — Iron deficiency without anemia is a common feature of moderate-to-severe atopic dermatitis (AD), according to a study published in Nutrients.

Sexually active patients with rheumatic disease who used teratogenic medications were over 5 times more likely to use long-acting reversible contraception if they received contraception counseling.

The researchers found that 3.5% of adults had catastrophic cost burdens during the first year in a 4-year period. HealthDay News — Overall, 17.4% of adults experienced cost burdens, and 9.9% ...

Findings from the FORTIS trial showed the mean change in hemoglobin at week 12 was 1.10 g/dL. The Food and Drug Administration (FDA) has expanded the approval of Accrufer® (ferric maltol) to include ...

The paper presents the policy messages in 2 parts: consequences of nicotine consumption and actions to address nicotine-induced adverse health effects. HealthDay News — Nicotine is toxic to the heart ...

Under a possible rule change outlined in a letter sent to supplement makers, the FDA would still require that warning on the package, but only once, rather than next to every health claim. HealthDay ...

The AAP represents about 67,000 pediatricians nationwide. The cuts come amid ongoing disagreements over vaccines.